Global Equine Pharmaceuticals and Supplements Sale, Insights Market Research Report 2020-2026
- IFF4163701
- 117 Pages
- January 2021
- Pharmaceuticals
The Equine Pharmaceuticals and Supplements market was valued at USD xx Million in 2019. It is projected to reach USD xx Million by 2025, growing at a CAGR of xx% from 2019. Europe, North America, and Asia-Pacific are still the main markets of Equine Pharmaceuticals and Supplements. Equine Pharmaceuticals and Supplements has low penetration in India, the Middle East and Africa, which makes these markets have great market potential. Market players are responding to new opportunities by expanding their global presence and product offerings. On the one hand, Equine Pharmaceuticals and Supplements manufacturers are dedicated to lowering their manufacturing cost; on the other hand, they try to provide more qualified products to customers. Besides, they are trying to broaden the applications of Equine Pharmaceuticals and Supplements.
This report includes estimations of the market size in terms of value (USD million). Both, top-down and bottom-up approaches have been used to estimate and validate the size of the Equine Pharmaceuticals and Supplements market and to estimate the size of various other dependent submarkets in the overall market. This research study involved the extensive usage of both primary and secondary data sources.
The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Main content of the study are:
To define, segment, and forecast the size of the Equine Pharmaceuticals and Supplements market with respect to type, application and region
To understand market conditions, company ranking, market structure, growth drivers by report
To historical and forecast the data of the market segments with respect to United States, EU, CIS, China, India, Japan, SEA, South America, Middle East, Oceania and the Rest of the World
To provide detailed information about the crucial factors that are influencing the growth of the market (drivers, restraints, opportunities, and challenges)
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
The major players in global market include
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Equine Pharmaceuticals and Supplements in these regions, from 2013 to 2024 (forecast), covering
North America
EU
CIS
China
India
Japan
SEA
South America
Middle East
Oceania
Row
On the basis of product, the Equine Pharmaceuticals and Supplements market is primarily split into
Pharmaceuticals
Supplements
On the basis on the end users/applications, this report covers
Thoroughbred Horse
Other Types of Horses
Chapter 1, to describe Equine Pharmaceuticals and Supplements Introduction, product types, technology, industrial chain, market risk, industry policy;
Chapter 2, to analyze of Equine Pharmaceuticals and Supplements industry raw material and manufacturing cost;
Chapter 3, to analyze the major manufacturers of Equine Pharmaceuticals and Supplements, with capacity, production, revenue, and price of Equine Pharmaceuticals and Supplements, from 2014 to 2020;
Chapter 4, to show the global market by regions, with capacity, production, revenue and market share of Equine Pharmaceuticals and Supplements, for each region, from 2014 to 2020;
Chapter 5, to show the global market by regions, with sales, import, export and market share of Equine Pharmaceuticals and Supplements, for each region, from 2014 to 2020;
Chapter 6 and 7, to analyze the market by countries, by type and by application with sales, revenue and market share by key countries in these regions;
Chapter 8, to analyze the major manufacturers of Equine Pharmaceuticals and Supplements, with basic information, and data of Equine Pharmaceuticals and Supplements, from 2014 to 2020;
Chapter 9 and 10, to describe Equine Pharmaceuticals and Supplements sales channel, distributors and competitive products
Chapter 11, to analyze new project investment feasibility
Chapter 12, Equine Pharmaceuticals and Supplements market forecast, by regions, type and application, with production, sales and revenue, from 2020 to 2025;
1 Equine Pharmaceuticals and Supplements Overview
1.1 Product Overview of Equine Pharmaceuticals and Supplements
1.1.1 Definition of Equine Pharmaceuticals and Supplements
1.1.2 Specifications of Equine Pharmaceuticals and Supplements
1.2 Equine Pharmaceuticals and Supplements Segment by Types
1.2.1 Global Equine Pharmaceuticals and Supplements Production Market Share by Types in 2019
1.2.2 Pharmaceuticals
1.2.3 Supplements
1.3 Equine Pharmaceuticals and Supplements Segment by Technology
1.4 Global Equine Pharmaceuticals and Supplements Segment by Applications
1.4.1 Global Equine Pharmaceuticals and Supplements Consumption Comparison by Applications (2015-2026)
1.4.2 Thoroughbred Horse
1.4.3 Other Types of Horses
1.5 Study Objectives and Content
1.6 Detailed Data Sources
2 Equine Pharmaceuticals and Supplements Raw Material and Manufacturing Cost Analysis
2.1 Equine Pharmaceuticals and Supplements Key Raw Materials Analysis
2.1.2 Price Trend of Key Raw Material A
2.1.4 Price Trend of Key Raw material B
2.3 Manufacturing Cost Structure Segment
2.3.1 Manufacturing Cost Structure Segment
2.3.2 Manufacturing Expenses Cost Structure Segment
2.4 Labor Costs Analysis by Regions
2.4.1 North America Costs Analysis
2.4.2 EU Costs Analysis
2.4.3 CIS Costs Analysis
2.4.4 China Costs Analysis
2.4.5 India Costs Analysis
2.4.6 Japan Costs Analysis
2.5 Manufacturing Process Analysis of Equine Pharmaceuticals and Supplements
2.6 Industry Policy Analysis of Equine Pharmaceuticals and Supplements
2.6.1 Direct Support for Policies and Macroeconomic Policies
2.6.2 Unfavorable Policy
3 Global Equine Pharmaceuticals and Supplements Market Share by Manufacturers
3.1 Global Equine Pharmaceuticals and Supplements Capacity, Production and Share by Manufacturers (2015-2020)
3.1.2 Major Manufacturer Production and Share by Manufacturers (2015-2020)
3.2 Major Manufacturer Revenue (Million USD) and Share by Manufacturers (2015-2020)
3.3 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2015-2020)
3.4 Equine Pharmaceuticals and Supplements Market Concentration Rate Analysis
3.4.1 Equine Pharmaceuticals and Supplements Market Concentration Rate
3.4.2 Equine Pharmaceuticals and Supplements Market Share of Top 3 and Top 5 Manufacturers
3.5 Equine Pharmaceuticals and Supplements Industry Mergers & Acquisitions, Expansion News
3.6 Potential Manufacturer or New Manufacturers
4 Global Equine Pharmaceuticals and Supplements Production by Regions (2015-2020)
4.1 Global Equine Pharmaceuticals and Supplements Capacity and Market Share by Regions (2015-2020)
4.2 Global Equine Pharmaceuticals and Supplements Production and Market Share by Regions (2015-2020)
4.3 2019 Global Equine Pharmaceuticals and Supplements Supply and Price by Season
4.4 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Regions (2013-2023)
4.4.1 Equine Pharmaceuticals and Supplements Market Size (Million USD) Comparison by Regions
4.4.2 North America Equine Pharmaceuticals and Supplements Status and Prospect (2015-2026)
4.4.3 EU Equine Pharmaceuticals and Supplements Status and Prospect (2015-2026)
4.4.4 CIS Equine Pharmaceuticals and Supplements Status and Prospect (2015-2026)
4.4.5 China Equine Pharmaceuticals and Supplements Status and Prospect (2015-2026)
4.4.6 India Equine Pharmaceuticals and Supplements Status and Prospect (2015-2026)
4.4.7 SEA Equine Pharmaceuticals and Supplements Status and Prospect (2015-2026)
4.4.8 South America Equine Pharmaceuticals and Supplements Status and Prospect (2015-2026)
4.4.9 Middle East Equine Pharmaceuticals and Supplements Status and Prospect (2015-2026)
4.4.10 Oceania Equine Pharmaceuticals and Supplements Status and Prospect (2015-2026)
4.4.11 Row Equine Pharmaceuticals and Supplements Status and Prospect (2015-2026)
4.5 Global Equine Pharmaceuticals and Supplements Price by Regions (2015-2026)
4.6 Global Equine Pharmaceuticals and Supplements Capacity, Production, Revenue (Million USD), Price and Gross Margin (2015-2020)
5 Global Equine Pharmaceuticals and Supplements Consumption by Regions (2015-2020)
5.1 Global Equine Pharmaceuticals and Supplements Consumption by Regions (2015-2020)
5.2 North America Equine Pharmaceuticals and Supplements Consumption (2015-2020)
5.3 EU Equine Pharmaceuticals and Supplements Consumption (2015-2020)
5.4 CIS Equine Pharmaceuticals and Supplements Consumption (2015-2020)
5.5 China Equine Pharmaceuticals and Supplements Consumption (2015-2020)
5.6 India Equine Pharmaceuticals and Supplements Consumption (2015-2020)
5.7 Japan Equine Pharmaceuticals and Supplements Consumption (2015-2020)
5.8 SEA Equine Pharmaceuticals and Supplements Consumption (2015-2020)
5.9 South America Equine Pharmaceuticals and Supplements Consumption (2015-2020)
5.10 Middle East Equine Pharmaceuticals and Supplements Consumption (2015-2020)
5.11 Oceania Equine Pharmaceuticals and Supplements Consumption (2015-2020)
5.12 Row Equine Pharmaceuticals and Supplements Consumption (2015-2020)
5.13 Distributors/Traders List
6 Global Equine Pharmaceuticals and Supplements Production, Revenue, Price Trend by Types
6.1 Global Equine Pharmaceuticals and Supplements Production and Market Share by Types (2015-2020)
6.1.1 Global Equine Pharmaceuticals and Supplements Production by Types (2015-2020)
6.1.2 Global Equine Pharmaceuticals and Supplements Production by Classification (2015-2020)
6.2 Global Equine Pharmaceuticals and Supplements Revenue (Million USD) and Market Share by Types (2015-2020)
6.2.1 Global Equine Pharmaceuticals and Supplements Revenue (Million USD) by Types (2015-2020)
6.2.2 Global Equine Pharmaceuticals and Supplements Revenue (Million USD) by Classification (2015-2020)
6.3 Global Equine Pharmaceuticals and Supplements Price by Type (2015-2020)
6.4 Global Equine Pharmaceuticals and Supplements Production Growth by Type (2015-2020)
7 Global Equine Pharmaceuticals and Supplements Market Share Analysis by Applications
7.1 Global Equine Pharmaceuticals and Supplements Consumption and Market Share by Applications (2015-2020)
7.2 Different Application Equine Pharmaceuticals and Supplements Product Driving Factors Analysis by Regions
7.3 North America Equine Pharmaceuticals and Supplements Consumption and Market Share by Applications (2015-2020)
7.4 EU Equine Pharmaceuticals and Supplements Consumption and Market Share by Applications (2015-2020)
7.5 CIS Equine Pharmaceuticals and Supplements Consumption and Market Share by Applications (2015-2020)
7.6 China Equine Pharmaceuticals and Supplements Consumption and Market Share by Applications (2015-2020)
7.7 India Equine Pharmaceuticals and Supplements Consumption and Market Share by Applications (2015-2020)
7.8 Japan Equine Pharmaceuticals and Supplements Consumption and Market Share by Applications (2015-2020)
7.9 SEA Equine Pharmaceuticals and Supplements Consumption and Market Share by Applications (2015-2020)
7.10 South America Equine Pharmaceuticals and Supplements Consumption and Market Share by Applications (2015-2020)
7.11 Middle East Equine Pharmaceuticals and Supplements Consumption and Market Share by Applications (2015-2020)
7.12 Oceania Equine Pharmaceuticals and Supplements Consumption and Market Share by Applications (2015-2020)
8 Global Equine Pharmaceuticals and Supplements Major Manufacturers Analysis
8.1 Boehringer Ingelheim
8.1.1 Boehringer Ingelheim Company Basic Information
8.1.2 Typical Product Picture, Application and Specification
8.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2015-2020)
8.1.4 Equine Pharmaceuticals and Supplements Company Profile
8.2 Merck Animal Health
8.2.1 Merck Animal Health Company Basic Information
8.2.2 Typical Product Picture, Application and Specification
8.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2015-2020)
8.2.4 Equine Pharmaceuticals and Supplements Company Profile
8.3 Zoetis
8.3.1 Zoetis Company Basic Information
8.3.2 Typical Product Picture, Application and Specification
8.3.3 Vetoquinol Equine Pharmaceuticals and Supplements Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2015-2020)
8.3.4 Equine Pharmaceuticals and Supplements Company Profile
8.4 Bayer Animal Health
8.4.1 Bayer Animal Health Company Basic Information
8.4.1 Bayer Animal Health Company Basic Information
8.4.3 Equine Pharmaceuticals and Supplements Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2015-2020)
8.4.4 Equine Pharmaceuticals and Supplements Company Profile
8.5 Elanco Animal Health
8.5.1 Elanco Animal Health Company Basic Information
8.5.2 Typical Product Picture, Application and Specification
8.5.3 Equine Pharmaceuticals and Supplements Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2015-2020)
8.5.4 Equine Pharmaceuticals and Supplements Company Profile
8.6 Dechra Veterinary Products
8.6.1 Dechra Veterinary Products Company Basic Information
8.6.2 Typical Product Picture, Application and Specification
8.6.3 Equine Pharmaceuticals and Supplements Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2015-2020)
8.6.4 Equine Pharmaceuticals and Supplements Company Profile
8.7 CEVA
8.7.1 CEVA Company Basic Information
8.7.2 Typical Product Picture, Application and Specification
8.7.3 Equine Pharmaceuticals and Supplements Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2015-2020)
8.7.4 Equine Pharmaceuticals and Supplements Company Profile
8.8 Virbac
8.8.1 Virbac Company Basic Information
8.8.2 Typical Product Picture, Application and Specification
8.8.3 Equine Pharmaceuticals and Supplements Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2015-2020)
8.8.4 Equine Pharmaceuticals and Supplements Company Profile
8.9 Norbrook Equine
8.9.1 Norbrook Equine Company Basic Information
8.9.2 Typical Product Picture, Application and Specification
8.9.3 Equine Pharmaceuticals and Supplements Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2015-2020)
8.9.4 Equine Pharmaceuticals and Supplements Company Profile
8.10 Kyoritsu Seiyaku
8.10.1 Kyoritsu Seiyaku Company Basic Information
8.10.2 Typical Product Picture, Application and Specification
8.10.3 Equine Pharmaceuticals and Supplements Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2015-2020)
8.10.4 Equine Pharmaceuticals and Supplements Company Profile
8.11 Vetoquinol
8.12 Protexin Healthcare
8.13 Audevard
8.14 Ouro Fino Saude
9. Marketing Strategy and Downstream Buyers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 B2B
9.1.4 B2C
9.2 Downstream Buyers
10 Equine Pharmaceuticals and Supplements Industry Future Trends and Competitive Products
10.1 The Latest Technology Development
10.2 Market Driven or Growth Reason
10.3 Relationship between Demand and Production
10.4 Competitive Products
11 New Project Investment Feasibility Analysis of Equine Pharmaceuticals and Supplements
11.1 New Project SWOT Analysis of Equine Pharmaceuticals and Supplements
11.2 New Project Investment Feasibility Analysis of Equine Pharmaceuticals and Supplements
11.2.1 Project Name
12.2.2 Investment Budget
11.2.3 Project Product Solutions
11.2.4 Project Schedule
12 Global Equine Pharmaceuticals and Supplements Market Forecast (2021-2026)
12.1 Global Equine Pharmaceuticals and Supplements Capacity, Production, Revenue Forecast (2021-2026)
12.1.1 Global Equine Pharmaceuticals and Supplements Capacity, Production and Growth Rate Forecast (2021-2026)
12.1.2 Global Equine Pharmaceuticals and Supplements Revenue (Million USD) and Growth Rate Forecast (2021-2026)
12.1.3 Global Equine Pharmaceuticals and Supplements Price and Trend Forecast (2021-2026)
12.2 Global Equine Pharmaceuticals and Supplements Production Forecast by Regions (2021-2026)
12.3 Regional Import, Export and Trade Forecast of Equine Pharmaceuticals and Supplements
12.4 Global Equine Pharmaceuticals and Supplements Consumption Forecast by Regions (2021-2026)
12.5 Global Equine Pharmaceuticals and Supplements Production, Revenue and Price Forecast by Type (2021-2026)
12.6 Global Equine Pharmaceuticals and Supplements Consumption Forecast by Application (2021-2026)
13 Research Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
